These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 26943714)
41. The first case report of a patient with acquired factor XIII deficiency in the context of autoimmune encephalitis. Soto I; Bernardo A; Arias T; Ramón C; Noval I; Palomo C Haemophilia; 2017 Sep; 23(5):e461-e464. PubMed ID: 28664679 [No Abstract] [Full Text] [Related]
42. Mechanisms of action of IVIG in adult onset Rasmussen's encephalitis. Buenz EJ; Howe CL Can J Neurol Sci; 2007 Feb; 34(1):108-9. PubMed ID: 17352358 [No Abstract] [Full Text] [Related]
44. [Pathophysiology and Prognostic Factors of Autoimmune Encephalitis]. Prüß H Fortschr Neurol Psychiatr; 2016 May; 84(5):264-70. PubMed ID: 27299785 [TBL] [Abstract][Full Text] [Related]
45. Apathy - Forme Fruste of Autoimmune Encephalitis. Kasinathan A; Adam RK; Sankhyan N; Singhi P Indian J Pediatr; 2018 Jul; 85(7):573. PubMed ID: 29532325 [No Abstract] [Full Text] [Related]
46. Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations. Zuliani L; Nosadini M; Gastaldi M; Spatola M; Iorio R; Zoccarato M; Mariotto S; De Gaspari P; Perini F; Ferrari S; Evoli A; Sartori S; Franciotta D; Giometto B Neurol Sci; 2019 Oct; 40(10):2017-2030. PubMed ID: 31161339 [TBL] [Abstract][Full Text] [Related]
47. High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis. Jang Y; Lee ST; Kim TJ; Jun JS; Moon J; Jung KH; Park KI; Chu K; Lee SK Sci Rep; 2018 Jan; 8(1):1012. PubMed ID: 29343812 [TBL] [Abstract][Full Text] [Related]
48. Encephalitis with antibodies against the GABA Chen X; Liu F; Li JM; Xie XQ; Wang Q; Zhou D; Shang H Neurol Res; 2017 Nov; 39(11):973-980. PubMed ID: 28974152 [TBL] [Abstract][Full Text] [Related]
49. Diagnostic and Therapeutic Approach to Autoimmune Neurologic Disorders. López-Chiriboga AS; Flanagan EP Semin Neurol; 2018 Jun; 38(3):392-402. PubMed ID: 30011418 [TBL] [Abstract][Full Text] [Related]
56. Autoimmune encephalitis management: MS centers and beyond. McKeon A; Zekeridou A Mult Scler; 2020 Nov; 26(13):1618-1626. PubMed ID: 32052703 [TBL] [Abstract][Full Text] [Related]
57. Sleep Disturbances in Patients with Autoimmune Encephalitis. Blattner MS; Day GS Curr Neurol Neurosci Rep; 2020 Jun; 20(7):28. PubMed ID: 32524504 [TBL] [Abstract][Full Text] [Related]
58. [Status epilepticus in paediatrics: a retrospective study and review of the literature]. Moreno-Medinilla EE; Negrillo-Ruano R; Calvo-Medina R; Mora-Ramírez MD; Martínez-Antón JL Rev Neurol; 2015 May; 60(9):394-400. PubMed ID: 25912700 [TBL] [Abstract][Full Text] [Related]
59. Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis. Yeshokumar AK; Sun LR; Klein JL; Baranano KW; Pardo CA Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27531146 [TBL] [Abstract][Full Text] [Related]
60. Progressive hearing loss and cerebellar ataxia in anti-Ma2-associated autoimmune encephalitis. Souza PV; Bortholin T; Pinto WB; Santos AJ Arq Neuropsiquiatr; 2017 Jan; 75(1):74-75. PubMed ID: 28099568 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]